David J Gordon

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

International journal of molecular sciences

Molecular cancer research : MCR

Oncogene

BMC cancer

University of Iowa

University of Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Iowa Jun 30 2014

United States

Associate Professor :: Pediatric Oncology

Dana Farber Cancer Institute Jul 05 2010 - Jun 01 2014

United States

Instructor :: Pediatric Oncology

Education History

University of Chicago Jul 01 1996 - Jun 01 2004

United States

PHD :: Medicine

Publications

Emma E Croushore, Christopher S Stipp, David J Gordon
EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells. International journal of molecular sciences 25 (16) (2024)
Emma E Croushore, Christopher S Stipp, David J Gordon
EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells. International journal of molecular sciences 25 (16) (2024)
Emma E Croushore, Stacia L Koppenhafer, Kelli L Goss, Elizabeth L Geary, David J Gordon
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress. Cancer research communications 3 (8) (2023)
Stacia L Koppenhafer, Kelli L Goss, Ellen Voigt, Emma Croushore, William W Terry, Jason Ostergaard, Peter M Gordon, David J Gordon
Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma. Oncogene 41 (20) (2022)
Jason Ostergaard, Leslie M Jonart, Maryam Ebadi, Stacia L Koppenhafer, David J Gordon, Peter M Gordon
Preclinical efficacy of prexasertib in acute lymphoblastic leukemia. British journal of haematology 194 (6) (2021)
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Varun V Monga, Rebecca D Dodd, Dawn E Quelle
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. International journal of molecular sciences 21 (8) (2020)
Kelli L Goss, Stacia L Koppenhafer, Torin Waters, William W Terry, Kuo-Kuang Wen, Meng Wu, Jason Ostergaard, Peter M Gordon, David J Gordon
The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors. Oncogene 40 (3) (2020)
Torin Waters, Kelli L Goss, Stacia L Koppenhafer, William W Terry, David J Gordon
Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication. BMC cancer 20 (1) (2020)
Visarut Buranasudja, Claire M Doskey, Adrienne R Gibson, Brett A Wagner, Juan Du, David J Gordon, Stacia L Koppenhafer, Joseph J Cullen, Garry R Buettner
Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage. Molecular cancer research : MCR 17 (10) (2019)
Stacia L Koppenhafer, Kelli L Goss, William W Terry, David J Gordon
Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2. Molecular cancer research : MCR 18 (1) (2019)

David J Gordon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David J Gordon